MiniMed Group (MMED) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Solventum is the larger company by market cap ($14.62 billion vs $5.38 billion), about 2.7 times the size, while MiniMed Group is growing revenue faster (+14.3% vs +0.9%). On valuation, Solventum trades at a lower forward P/E (11.9x vs 30.0x for MiniMed Group). Solventum converts more of its revenue into profit, with a net margin of 18.7% versus -10.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMED | SOLV |
|---|---|---|
| Share price | $19.11 | $85.88 |
| Market cap | $5.38B | $14.62B |
| 1-day change | -2.70% | -1.33% |
| YTD return | — | +8.38% |
| 1-year return | — | +19.01% |
| P/E ratio (TTM) | — | 10.66 |
| Forward P/E | 29.99 | 11.88 |
| EPS (TTM) | $-1.49 | $8.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.10B | $8.32B |
| Revenue growth (YoY) | +14.25% | +0.86% |
| Net income (latest FY) | $-333.00M | $1.56B |
| Gross margin | 54.16% | 53.47% |
| Operating margin | -6.13% | 26.20% |
| Net margin | -10.74% | 18.69% |
| 52-week high | $24.43 | $94.16 |
| 52-week low | $10.65 | $62.38 |
| Distance from 52-week high | -21.78% | -8.79% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +29.20% | +9.82% |
| Average volume | 2.35M | 1.02M |
| Shares outstanding | 281.35M | 170.22M |
| Employees | 8,000 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Solventum is about 2.7 times larger than MiniMed Group by market value ($14.62B vs $5.38B).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus -10.7 cents for MiniMed Group.
- MiniMed Group grew revenue faster in its latest fiscal year (+14.25% vs +0.86%).
About MiniMed Group
MMED stock →MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
Health Care · Medical/Dental Instruments · 8,000 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
MMED vs SOLV FAQ
Which is bigger, MiniMed Group or Solventum?
Solventum (SOLV) is larger, with a market capitalization of $14.62B compared with $5.38B for MiniMed Group (MMED).
Are MiniMed Group and Solventum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.